What's the Cost of Aplastic anemia Diagnosis and Treatment in India?
Aplastic anemia treatment cost in India depends on the diagnostic work-up and treatment approach. A bone marrow biopsy ranges from AUD $420 to AUD $650. Bone marrow transplantation runs from AUD $45,300 to AUD $60,400. Costs vary with donor match, hospital type, admission length and medicines. Compared with Australia and other Western countries, treatment may cost around 50โ70% less. Delhi, Gurgaon and Bengaluru are key cities to compare.
- Bone marrow biopsy: AUD $420 โ AUD $650
- Extended blood analysis: AUD $60 โ AUD $170
- Consultation with a hematologist: AUD $60 โ AUD $91
- Bone marrow transplantation: AUD $45,300 โ AUD $60,400
- Allogeneic bone marrow transplantation from a related donor: AUD $37,800 โ AUD $42,300
- Allogeneic bone marrow transplantation from an unrelated donor: AUD $42,300 โ AUD $60,400
Bookimed Expert Insight: For donor-transplant candidates, BLK Super Speciality Hospital in Delhi offers relevant experience. Its unit performs over 100 bone marrow transplants annually. It was also the first in India to perform multiple-donor transplants. Australian patients seeking an aplastic-anaemia specialist can consider Dr Girish Badarkhe at HCG Manavata Cancer Centre. He specialises in aplastic anaemia and performs allogeneic and haploidentical bone marrow transplants. These details can help patients match their donor needs with a relevant team before travelling.
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees โ just official clinic prices. Pay at the clinic for Aplastic anemia treatment and use a flexible instalment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Aplastic anemia treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Aplastic anemia treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Aplastic anemia Treatment Centres in India for Australians: 11 Verified Options and AUD Prices
Global Hospital Chennai
Sandeep Attawar








Dr. Rela Institute & Medical Centre
Get a Medical Assessment for Aplastic anemia Treatment in India: consult with 7 experienced doctors for Australian patients now
View all Doctors
Mallikarjun Kalashetty
Dr. Kalashetty specializes in bone marrow transplantation for aplastic anemia at Manipal Hospitals.
- Oncohematologist with expertise in blood disorders
- Focuses on bone marrow transplantation procedures
- Works at one of India's leading healthcare institutions

Gaurav Kharya
Pediatric hematologist-oncologist specializing in aplastic anemia and bone marrow transplants.
- Expertise in pediatric hematology and oncology
- Specializes in bone marrow transplantation
- Focuses on treating children with aplastic anemia

Deenadayalan Munirathnam
Pediatric hematologist-oncologist specializing in bone marrow transplants at Global Hospital Mumbai.
- Expertise in treating pediatric blood disorders and cancers
- Specialized in bone marrow transplant procedures
- Affiliated with a leading hospital in Mumbai

Rahul Bhargava
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Aplastic anemia Treatment in India
What infrastructure should a patient look for when choosing an Indian hospital for aplastic anaemia treatment?
Patients should prioritise Indian hospitals with dedicated bone marrow transplant units. These units must feature HEPA-filtered, positive-pressure isolation rooms. Quality infrastructure needs NABL-certified laboratories for HLA typing and 24/7 blood banks capable of leukoreduction. These facilities protect immunocompromised patients from infections while allowing for rapid donor matching.
- Infection control: Built-in HEPA filtration systems maintain sterile environments to prevent bacterial or fungal growth.
- Blood services: On-site labs must provide irradiated blood products to reduce graft rejection risks.
- Accreditation standards: JCI or NABH certifications confirm the hospital follows international safety and hygiene protocols.
- Diagnostic depth: Infrastructure should support frequent bone marrow biopsies and high-resolution flow cytometry onsite.
Bookimed Expert Insight: Manipal Hospitals and Global Hospital Chennai maintain NABL-certified labs alongside JCI accreditation. This dual certification is vital for aplastic anaemia. It ensures diagnostic accuracy for complex donor matching. Large networks like Apollo also treat over 1,000,000 patients annually. This volume typically means faster access to specialised drugs like Anti-Thymocyte Globulin.
Patient Consensus: Patients note it is vital to select a tertiary centre with 24/7 emergency care. This is necessary for treating neutropenic fevers. They also emphasise confirming blood product safety and infection protocols before arrival in India.
What is the preferred or first-line treatment for aplastic anaemia in India?
Allogeneic bone marrow transplant (BMT) from a matched sibling is the first-line treatment for aplastic anaemia in India. This gold-standard approach is preferred for patients under 50. For those without donors, triple-drug immunosuppressive therapy serves as the primary alternative. This uses ATG, cyclosporine, and eltrombopag.
- Sibling transplant: Preferred curative path for younger patients with a human leukocyte antigen match.
- Triple therapy: Combines immunosuppressants and eltrombopag to stimulate marrow recovery without major surgery.
- Specialised centres: Facilities like Artemis Hospitals and Apollo Hospital Indraprastha hold JCI accreditation.
- Expert specialists: Dr Rahul Bhargava has established low-cost BMT centres and completed 1,000+ transplants.
Bookimed Expert Insight: India is a global hub for bone marrow transplants. Apollo Hospital Indraprastha is the largest transplant centre outside the USA. Many countries focus only on related donors. However, major Indian clinics like Global Hospital Chennai and BLK Super Speciality Hospital specialise in both. They perform related and unrelated donor transplants for over 1,000,000 international patients annually.
How do Indian hospitals manage aplastic anaemia cases when a matched sibling donor is unavailable?
Indian hospitals manage aplastic anaemia without a matched sibling through triple immunosuppressive therapy or alternative donor transplants. Specialist centres use haploidentical protocols or search registries for unrelated matches. JCI-accredited facilities rely on supportive care to prevent infections during prolonged recovery periods.
- Immunosuppressive therapy: Combined Anti-Thymocyte Globulin, Cyclosporine, and Eltrombopag help restore bone marrow function.
- Haploidentical transplant: Half-matched relatives serve as donors using the Post-Transplant Cyclophosphamide protocol.
- Unrelated donor: Hospitals like Apollo Indraprastha search local and international registries for matches.
- Supportive care: Strict infection prophylaxis and blood transfusions bridge the gap during donor searches.
Bookimed Expert Insight: Indian clinics such as Apollo Hospital Indraprastha and Global Hospital Chennai serve over 1,000,000 and 80,000 patients annually. This massive volume allows surgeons like Dr Rahul Bhargava to complete 1,000+ transplants. Their experience with complex alternative donor cases has led to low-cost transplant centres. This makes high-level haematology care more accessible to those without a perfect family match.
Patient Consensus: Patients in India find that larger transplant centres offer better donor-search pathways. This is especially helpful when sibling matches fail. Many emphasise the importance of strict infection control while waiting for therapy to work.
Why does patient age influence the treatment outlook for aplastic anaemia in India?
Patient age in India determines if a person receives a curative bone marrow transplant or immunosuppressive therapy. Younger patients under 40 often undergo transplants with 80% to 90% survival rates. Older patients typically receive drug-based therapy to avoid severe complications and infections.
- Transplant eligibility: Patients under 40 are prioritised for matched sibling donor transplants.
- Therapy shift: Patients over 40 usually receive immunosuppressive therapy to reduce fatal risks.
- Recovery resilience: Older patients face slower marrow recovery and higher bacterial infection risks.
- Malignant transformation: Vulnerable marrow in older patients has a higher risk of genetic mutations.
- Economic factors: Families in India often prioritise funding curative transplants for children and workers.
Bookimed Expert Insight: Specialist centres in India, like Apollo Hospital Indraprastha, manage some of the largest transplant programs globally. Age remains a primary factor. However, clinics like BLK Super Speciality Hospital use diagnostic tools from Europe to assess physiological age. This allows fit patients over 40 to occasionally access transplant options usually reserved for the young.
Patient Consensus: Patients in India emphasise that finding a donor quickly matters as much as age. Many note that choosing a centre with significant aplastic anaemia experience helps manage infection risks. High-experience centres in Bengaluru or Delhi are preferred during the long recovery phase.
How do success rates for aplastic anaemia treatment in India compare globally?
Leading Indian medical centres achieve allogeneic bone marrow transplant success rates between 70% and 90% for matched related donors. These figures match global standards. Top-tier hospitals in Delhi and Bengaluru hold JCI accreditation. They perform high volumes of complex haematological procedures annually.
- Matched donor success: Indian centres report 70% to 90% survival, mirroring Western 5-year benchmarks.
- Paediatric outcomes: Survival rates for patients under 20 reach 90% to 100% in premier facilities.
- Unrelated donor efficacy: Success rates range from 36% to 65% due to higher rejection risks.
- Immunosuppressive therapy: Leading institutions report 60% to 80% response rates using standard drug protocols.
Bookimed Expert Insight: India houses one of the largest transplantation networks globally. Apollo Hospital Indraprastha handles massive volumes, serving 1,000,000 patients annually. Specialist Dr Rahul Bhargava has performed over 1,000 transplants. High clinical experience often leads to better management of graft-versus-host disease than lower-volume centres.
Patient Consensus: Patients note that infection control and donor matching are the most critical factors for recovery. They suggest comparing clinic experience with various donor types, including matched sibling and haploidentical options.














